ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2025 Financial Results and Participation at Upcoming Conferences

ARS Pharmaceuticals (Nasdaq: SPRY) will host a conference call and webcast on March 9, 2026 at 5:30 a.m. PT / 8:30 a.m. ET to discuss fourth quarter and full year 2025 financial results and business highlights.

Rhea-AI Summary

ARS Pharmaceuticals (Nasdaq: SPRY) will host a conference call and webcast on March 9, 2026 at 5:30 a.m. PT / 8:30 a.m. ET to discuss fourth quarter and full year 2025 financial results and business highlights.

Management will also participate in investor conferences on Feb 25, Mar 11, and Mar 22, 2026; webcasts and replay access are available via the company’s Events & Presentations page for 30 days.

Argus Feb 23 session

+2.33% close to close Open Argus

Details

News Market Reaction – SPRY

In the Feb 23 session, SPRY gained 2.33%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement outlines the timing of SPRY’s Q4 and full-year 2025 earnings call on March 9, 2026...

Analysis

This announcement outlines the timing of SPRY’s Q4 and full-year 2025 earnings call on March 9, 2026 and participation in several investor conferences through late March. It continues a consistent pattern of communicating results schedules and outreach plans. Investors may focus on upcoming financial disclosures, cash trends, and commercialization updates in those events, while also tracking any subsequent regulatory filings or major shareholder disclosures noted in recent SEC reports.

Key Figures

Earnings call date: March 9, 2026 Call time PT: 5:30 a.m. PT Call time ET: 8:30 a.m. ET +4 more

Earnings call date

March 9, 2026

Q4 and full-year 2025 financial results conference call

Call time PT

5:30 a.m. PT

Scheduled start time for earnings conference call

Call time ET

8:30 a.m. ET

Scheduled start time for earnings conference call

Oppenheimer conference date

February 25, 2026

10th Annual Oppenheimer Emerging Growth Conference participation

Leerink conference date

March 11, 2026

Leerink Conference participation

ROTH conference date

March 22, 2026

38th Annual ROTH Conference participation

Webcast replay period

30 days

Replay availability after events on company website

Previous Conferences,earnings Reports

5 past events · Latest: Nov 03

Same Type 5 events

1. Nov 03

   Earnings call notice

   24h Move

   -3.8%

   Announced Q3 2025 earnings call timing and webcast details.

2. Aug 04

   Earnings call notice

   24h Move

   +1.2%

   Scheduled Q2 2025 results call and provided access instructions.

3. May 05

   Earnings call notice

   24h Move

   -1.4%

   Set date and time for Q1 2025 results and webcast.

4. Mar 03

   Earnings & conferences

   24h Move

   +3.2%

   Announced FY 2024 call plus participation in major investor conferences.

5. Nov 06

   Earnings & conferences

   24h Move

   +2.6%

   Outlined Q3 2024 call and multiple upcoming healthcare conferences.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to anaphylaxis, today announced the company will host a conference call and webcast on Monday, March 9, 2026 at 5:30 a.m. PT / 8:30 a.m. ET to discuss its fourth quarter and full year 2025 financial results and business highlights. Dial-in information for conference participants may be obtained by registering for the event.

In addition, ARS Pharma Management will be participating at several upcoming investor conferences:

• 10^th Annual Oppenheimer Emerging Growth Conference: February 25, 2026
  
• Leerink Conference: March 11, 2026
  A live webcast of the presentation will be available here.
• 38^th Annual ROTH Conference: March 22, 2026
  

To access the webcast and slides, please visit the Events & Presentations page in the “Investors & Media” section of the Company’s website. A replay of the webcast will be available for 30 days following the event.

About ARS Pharmaceuticals, Inc.
ARS Pharma is a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to anaphylaxis. The Company is commercializing neffy^® (trade name EURneffy^® in the EU and 优敏速^® in China), an epinephrine nasal spray indicated in the U.S. for emergency treatment of Type I allergic reactions, including anaphylaxis, in adult patients and pediatric patients 4 years of age and older who weigh 33 lbs. or greater, and in the EU for emergency treatment of allergic reactions (anaphylaxis) due to insect stings or bites, foods, medicinal products, and other allergens as well as idiopathic or exercise induced anaphylaxis in adults and children who weigh 30 kg or greater. For more information, visit www.ars-pharma.com.

ARS Investor Contact:
Justin Chakma
ARS Pharmaceuticals
justinc@ars-pharma.com

ARS Media Contact:
Christy Curran
Sam Brown Inc.
615.414.8668
christycurran@sambrown.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will ARS Pharmaceuticals (SPRY) report Q4 and full year 2025 results and how can I join?

The company will report on March 9, 2026 at 5:30 a.m. PT / 8:30 a.m. ET. According to the company, investors can join via a conference call and live webcast by registering to obtain dial-in details and online access.

Will ARS Pharmaceuticals (SPRY) provide a replay of the March 9, 2026 webcast and for how long?

Yes, a replay will be available for 30 days following the event. According to the company, the webcast replay and presentation slides can be accessed on the Events & Presentations page in Investors & Media.

Which investor conferences will ARS Pharmaceuticals (SPRY) management attend in early 2026?

Management will attend conferences on Feb 25, Mar 11, and Mar 22, 2026. According to the company, these include the Oppenheimer Emerging Growth, Leerink, and the 38th Annual ROTH conferences with live webcasts where available.

How can investors access ARS Pharmaceuticals (SPRY) presentation slides for the upcoming conferences?

Presentation slides and webcasts are available on the company’s Investors & Media Events & Presentations page. According to the company, slides and webcast links will be posted for viewing and replay access.

What time zones apply to ARS Pharmaceuticals (SPRY) March 9, 2026 earnings call and why is that important?

The call is scheduled for 5:30 a.m. PT / 8:30 a.m. ET on March 9, 2026. According to the company, listing both time zones helps global investors plan participation via dial-in or webcast registration.